{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:53:21Z","timestamp":1776488001613,"version":"3.51.2"},"reference-count":88,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Colorectal cancer (CRC) is a heterogeneous disease driven by complex genetic, epigenetic, and microenvironmental alterations. Members of the PR domain-containing (PRDM) protein family have emerged as context-dependent regulators of CRC initiation, progression, tumor cell plasticity, immune modulation, and therapeutic response. Accumulating evidence highlights divergent roles for PRDM proteins as tumor suppressors, oncogenes, or isoform-dependent dual-function regulators. Collectively, PRDM family members represent a central node of transcriptional\/epigenetic control in CRC biology, with significant potential as biomarkers for early detection, prognosis, and treatment stratification, as well as promising candidates for epigenetic and pathway-directed therapeutic strategies.<\/jats:p>","DOI":"10.3390\/ijms27083392","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:55:12Z","timestamp":1775807712000},"page":"3392","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PRDM Proteins Orchestrate Colorectal Cancer Tumorigenesis"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7621-488X","authenticated-orcid":false,"given":"Erika","family":"Di Zazzo","sequence":"first","affiliation":[{"name":"Department of Medicine and Health Sciences \u201cV. Tiberio\u201d, University of Molise, 86100 Campobasso, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6377-5872","authenticated-orcid":false,"given":"Carmela","family":"Sorrentino","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4496-4894","authenticated-orcid":false,"given":"Monica","family":"Rienzo","sequence":"additional","affiliation":[{"name":"Department of Environmental, Biological, and Pharmaceutical Sciences and Technologies, University of Campania \u201cLuigi Vanvitelli\u201d, 81100 Caserta, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0703-7231","authenticated-orcid":false,"given":"Donatella","family":"Fiore","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7066-174X","authenticated-orcid":false,"given":"Maria Chiara","family":"Proto","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Enna \u201cKore\u201d, 94100 Enna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-4261","authenticated-orcid":false,"given":"Amelia","family":"Casamassimi","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0576-2955","authenticated-orcid":false,"given":"Patrizia","family":"Gazzerro","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-4835","authenticated-orcid":false,"given":"Ciro","family":"Abbondanza","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/biology2010107","article-title":"PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation","volume":"2","author":"Abbondanza","year":"2013","journal-title":"Biology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.gde.2016.03.009","article-title":"The role of PRDMs in cancer: One family, two sides","volume":"36","author":"Mzoughi","year":"2016","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Casamassimi, A., Rienzo, M., Di Zazzo, E., Sorrentino, A., Fiore, D., Proto, M.C., Moncharmont, B., Gazzerro, P., Bifulco, M., and Abbondanza, C. (2020). Multifaceted Role of PRDM Proteins in Human Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072648"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/febs.15844","article-title":"The duality of PRDM proteins: Epigenetic and structural perspectives","volume":"289","author":"Schwarz","year":"2022","journal-title":"FEBS J."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Clifton, M.K., Westman, B.J., Thong, S.Y., O\u2019cOnnell, M.R., Webster, M.W., Shepherd, N.E., Quinlan, K.G., Crossley, M., Blobel, G.A., and Mackay, J.P. (2014). The identification and structure of an N-terminal PR domain show that FOG1 is a member of the PRDM family of proteins. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106011"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"M\u00e1rmol, I., S\u00e1nchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., and Rodriguez Yoldi, M.J. (2017). Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18010197"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5416923","DOI":"10.1155\/2018\/5416923","article-title":"Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cells Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/S1470-2045(19)30172-X","article-title":"Explaining the unexplainable: Discrepancies in results from the CALGB\/SWOG 80405 and FIRE-3 studies","volume":"20","author":"Aderka","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sorrentino, A., Federico, A., Rienzo, M., Gazzerro, P., Bifulco, M., Ciccodicola, A., Casamassimi, A., and Abbondanza, C. (2018). PR\/SET Domain Family and Cancer: Novel Insights from the Cancer Genome Atlas. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103250"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rienzo, M., Sorrentino, A., Di Zazzo, E., Di Donato, M., Carafa, V., Marino, M.M., De Rosa, C., Gazzerro, P., Castoria, G., and Altucci, L. (2021). Searching for a Putative Mechanism of RIZ2 Tumor-Promoting Function in Cancer Models. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.583533"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Di Zazzo, E., Rienzo, M., Casamassimi, A., Gazzerro, P., and Abbondanza, C. (2024). Recent Updates on PRDM2 in Colorectal Cancer. Front. Biosci. (Landmark Ed.), 29.","DOI":"10.31083\/j.fbl2909316"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1002\/cjp2.348","article-title":"Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite-instable colorectal cancers","volume":"10","author":"Bleijenberg","year":"2024","journal-title":"J. Pathol. Clin. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1186\/s12967-023-04621-6","article-title":"RIZ2 at the crossroad of the EGF\/EGFR signaling in colorectal cancer","volume":"21","author":"Salvati","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bond, C.E., Bettington, M.L., Pearson, S.A., McKeone, D.M., Leggett, B.A., and Whitehall, V.L. (2015). Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1011-9"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41698-023-00488-4","article-title":"Profiling the heterogeneity of colorectal cancer consensus molecular subtypes using spatial transcriptomics","volume":"8","author":"Valdeolivas","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/jnci\/djab106","article-title":"Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis","volume":"114","author":"Sommeijer","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jcb.25262","article-title":"PRDM1, a Tumor-Suppressor Gene, is Induced by Genkwadaphnin in Human Colon Cancer SW620 Cells","volume":"117","author":"Kang","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"ref_20","first-page":"E5066","article-title":"PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids","volume":"115","author":"Liu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00262-020-02593-w","article-title":"Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer","volume":"69","author":"Saleh","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"98646","DOI":"10.18632\/oncotarget.21713","article-title":"Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth","volume":"8","author":"Pandzic","year":"2017","journal-title":"Oncotarget"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"106118","DOI":"10.1016\/j.biocel.2021.106118","article-title":"EVI1 promotes metastasis by downregulating TIMP2 in metastatic colon and breast cancer cells","volume":"142","author":"Suresh","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41419-022-05513-1","article-title":"A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2019.07.058","article-title":"A Multigene Model for Predicting Tumor Responsiveness After Preoperative Chemoradiotherapy for Rectal Cancer","volume":"105","author":"Cho","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1038\/onc.2013.283","article-title":"Prdm5 suppresses Apc(Min)-driven intestinal adenomas and regulates monoacylglycerol lipase expression","volume":"33","author":"Galli","year":"2014","journal-title":"Oncogene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1158\/1078-0432.CCR-07-0305","article-title":"PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer","volume":"13","author":"Watanabe","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_28","first-page":"S118","article-title":"Network analysis of grade II into grade III transition in rectum cancer patients","volume":"11","author":"Mansouri","year":"2018","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e6941","DOI":"10.7717\/peerj.6941","article-title":"Transcriptional regulation of Bcl-2 gene by the PR\/SET domain family member PRDM10","volume":"7","author":"Chen","year":"2019","journal-title":"PeerJ"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ueg2.12696","article-title":"Early colorectal cancer diagnosis: A novel methylated stool DNA model enhanced the diagnostic efficiency","volume":"13","author":"Yun","year":"2025","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s12094-019-02239-z","article-title":"PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer","volume":"22","author":"Igarashi","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.devcel.2021.12.006","article-title":"YAP1 and PRDM14 converge to promote cell survival and tumorigenesis","volume":"57","author":"Kim","year":"2022","journal-title":"Dev. Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12957-022-02487-4","article-title":"Genome-wide analysis of cell-Free DNA methylation profiling with MeDIP-seq identified potential biomarkers for colorectal cancer","volume":"20","author":"Zhang","year":"2022","journal-title":"World J. Surg. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41419-022-05402-7","article-title":"PRDM15 interacts with DNA-PK-Ku complex to promote radioresistance in rectal cancer by facilitating DNA damage repair","volume":"13","author":"Yu","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"168097","DOI":"10.1016\/j.bbadis.2025.168097","article-title":"PRDM15 promotes colorectal carcinogenesis by transcriptionally repressing USP10 to destabilize p53","volume":"1872","author":"Wu","year":"2026","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"111634","DOI":"10.1016\/j.cellsig.2025.111634","article-title":"DNA methylation-induced suppression of PRDM16 in colorectal cancer metastasis through the PPAR\u03b3\/EMT pathway","volume":"127","author":"Wang","year":"2025","journal-title":"Cell. Signal."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.7150\/thno.95485","article-title":"LINC00982-encoded protein PRDM16-DT regulates CHEK2 splicing to suppress colorectal cancer metastasis and chemoresistance","volume":"14","author":"Hu","year":"2024","journal-title":"Theranostics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3892\/mmr.2020.11737","article-title":"Long non coding RNA ZFPM2 AS1 promotes colorectal cancer progression by sponging miR 137 to regulate TRIM24","volume":"23","author":"Xiao","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1389557522666220516125842","article-title":"ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple Cancer Types","volume":"23","author":"Tan","year":"2023","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e71534","DOI":"10.1002\/cam4.71534","article-title":"Distinct Molecular and Prognostic Profiles of Left- and Right-Sided Colorectal Cancer Revealed by NGS Analysis: The Role of SMAD4 and SETD2 Mutations","volume":"15","author":"Zhao","year":"2026","journal-title":"Cancer Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/gcc.22481","article-title":"The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer","volume":"56","author":"Slattery","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1541-7786.MCR-13-0286-T","article-title":"Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans","volume":"12","author":"Weige","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1073\/pnas.0605562104","article-title":"BLIMP1 regulates cell growth through repression of p53 transcription","volume":"104","author":"Yan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","first-page":"4516","article-title":"MiR-223-3p promotes the proliferation, invasion and migration of colon cancer cells by negative regulating PRDM1","volume":"11","author":"Chai","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s42003-021-02078-1","article-title":"Mucosal ribosomal stress-induced PRDM1 promotes chemoresistance via stemness regulation","volume":"4","author":"Kim","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00262-016-1951-1","article-title":"Inclusion of BLIMP-1+ effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: A pilot study","volume":"66","author":"McCall","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.4049\/jimmunol.1801368","article-title":"High-Dimensional Mass Cytometric Analysis Reveals an Increase in Effector Regulatory T Cells as a Distinguishing Feature of Colorectal Tumors","volume":"202","author":"Norton","year":"2019","journal-title":"J. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.immuni.2025.09.008","article-title":"The transcriptional repressor BLIMP1 enforces TCF-1-dependent and -independent restriction of the memory fate of CD8+ T cells","volume":"58","author":"Murphy","year":"2025","journal-title":"Immunity"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e15207","DOI":"10.1002\/advs.202515207","article-title":"PRDM1+ Malignant Cells Mediate an Immunosuppressive Landscape and Resistance to Neoadjuvant Chemoradiotherapy and Immunotherapy in Esophageal Squamous Cell Carcinoma","volume":"20","author":"Shen","year":"2026","journal-title":"Adv. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bbagrm.2018.06.002","article-title":"Human PRDM2: Structure, function and pathophysiology","volume":"1861","author":"Sorrentino","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) Gene Regul. Mech."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s003359900195","article-title":"Riz maps to distal chromosome 4 near genes involved in tumorigenesis and nerve degeneration","volume":"7","author":"Mock","year":"1996","journal-title":"Mamm. Genome"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/geno.1996.0249","article-title":"Physical mapping of the retinoblastoma interacting zinc finger gene RIZ to D1S228 on chromosome 1p36","volume":"34","author":"Buyse","year":"1996","journal-title":"Genomics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1054\/bjoc.2000.1667","article-title":"Preferential loss of a polymorphic RIZ allele in human hepatocellular carcinoma","volume":"84","author":"Fang","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1002\/cncr.29465","article-title":"Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women\u2019s Health Initiative Observational Study","volume":"121","author":"Cheng","year":"2015","journal-title":"Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1158\/0008-5472.CAN-14-0013","article-title":"Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer","volume":"74","author":"Mouradov","year":"2014","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/annonc\/mdh045","article-title":"Clinicopathological significance of microsatellite instability and mutated RIZ in colorectal cancer","volume":"15","author":"Emterling","year":"2004","journal-title":"Ann. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10350-005-0293-4","article-title":"Accumulation profile of frameshift mutations during development and progression of colorectal cancer from patients with hereditary nonpolyposis colorectal cancer","volume":"49","author":"Yamaguchi","year":"2006","journal-title":"Dis. Colon Rectum"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1080>3.0.CO;2-V","article-title":"RIZ, the retinoblastoma protein interacting zinc finger gene, is mutated in genetically unstable cancers of the pancreas, stomach, and colorectum","volume":"30","author":"Sakurada","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1073\/pnas.040579497","article-title":"Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis","volume":"97","author":"Chadwick","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","first-page":"4701","article-title":"Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability","volume":"60","author":"Piao","year":"2000","journal-title":"Cancer Res."},{"key":"ref_61","first-page":"1796","article-title":"Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers","volume":"61","author":"Jiang","year":"2001","journal-title":"Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Palma, P., Cuadros, M., Conde-Mu\u00ed\u00f1o, R., Olmedo, C., Cano, C., Segura-Jim\u00e9nez, I., Blanco, A., Bueno, P., Ferr\u00f3n, J.A., and Medina, P. (2013). Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074034"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3748\/wjg.v8.i5.841","article-title":"Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines","volume":"8","author":"Chen","year":"2002","journal-title":"World J. Gastroenterol."},{"key":"ref_64","first-page":"354","article-title":"Evi-1 Influence on Clinical Progress of Colorectal Cancer Patients","volume":"50","author":"Zhu","year":"2020","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12253-016-0112-3","article-title":"Intratumoral Heterogeneity of Frameshift Mutations in MECOM Gene is Frequent in Colorectal Cancers with High Microsatellite Instability","volume":"23","author":"Choi","year":"2017","journal-title":"Pathol. Oncol. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41419-017-0036-1","article-title":"Ecotropic viral integration site 1 promotes metastasis independent of epithelial mesenchymal transition in colon cancer cells","volume":"9","author":"Nayak","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.biocel.2013.04.032","article-title":"EVI1 targets \u0394Np63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells","volume":"45","author":"Nayak","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.febslet.2011.01.033","article-title":"The Evi1, microRNA-143, K-Ras axis in colon cancer","volume":"585","author":"Gao","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mc.21852","article-title":"Overexpression of Evi-1 oncoprotein represses TGF-\u03b2 signaling in colorectal cancer","volume":"52","author":"Deng","year":"2013","journal-title":"Mol. Carcinog."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biocel.2014.05.037","article-title":"Physical and functional interaction of the proto-oncogene EVI1 and tumor suppressor gene HIC1 deregulates Bcl-xL mediated block in apoptosis","volume":"53","author":"Pradhan","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1038\/s41467-023-42228-z","article-title":"Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development","volume":"14","author":"Shimomura","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100776","DOI":"10.1016\/j.mcpro.2024.100776","article-title":"(Sialyl)Lewis Antigen Expression on Glycosphingolipids, N-, and O-Glycans in Colorectal Cancer Cell Lines is Linked to a Colon-Like Differentiation Program","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cell. Proteom."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"100239","DOI":"10.1016\/j.mcpro.2022.100239","article-title":"High Diversity of Glycosphingolipid Glycans of Colorectal Cancer Cell Lines Reflects the Cellular Differentiation Phenotype","volume":"21","author":"Wang","year":"2022","journal-title":"Mol. Cell. Proteom."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/ptr.6626","article-title":"Matrine triggers colon cancer cell apoptosis and G0\/G1 cell cycle arrest via mediation of microRNA-22","volume":"34","author":"Liu","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Makondi, P.T., Chu, C.M., Wei, P.L., and Chang, Y.J. (2017). Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180616"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1038\/sj.onc.1207615","article-title":"PRDM5 is silenced in human cancers and has growth suppressive activities","volume":"23","author":"Deng","year":"2004","journal-title":"Oncogene"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41571-019-0241-1","article-title":"Biomarker-guided therapy for colorectal cancer: Strength in complexity","volume":"17","author":"Sveen","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2019.06.043","article-title":"Strategies for Colorectal Cancer Screening","volume":"158","author":"Ladabaum","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Rahman, R., Islam, T., Gov, E., Turanli, B., Gulfidan, G., Shahjaman, M., Banu, N.A., Mollah, N.H., Arga, K.Y., and Moni, M.A. (2019). Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis. Medicina, 55.","DOI":"10.3390\/medicina55010020"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2102674","DOI":"10.1155\/2016\/2102674","article-title":"Reduced Representation Bisulfite Sequencing Determination of Distinctive DNA Hypermethylated Genes in the Progression to Colon Cancer in African Americans","volume":"2016","author":"Ashktorab","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Burghel, G.J., Lin, W.Y., Whitehouse, H., Brock, I., Hammond, D., Bury, J., Stephenson, Y., George, R., and Cox, A. (2013). Identification of candidate driver genes in common focal chromosomal aberrations of microsatellite stable colorectal cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0083859"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/15592294.2021.1950991","article-title":"DNA methylome in visceral adipose tissue can discriminate patients with and without colorectal cancer","volume":"17","author":"Izquierdo","year":"2022","journal-title":"Epigenetics"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1074\/jbc.M808989200","article-title":"SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells","volume":"284","author":"Takahata","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"117281","DOI":"10.1016\/j.biopha.2024.117281","article-title":"Unravelling the function of prdm16 in human tumours: A comparative analysis of haematologic and solid tumours","volume":"178","author":"Shi","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12967-019-02151-8","article-title":"Two precision medicine predictive tools for six malignant solid tumors: From gene-based research to clinical application","volume":"17","author":"Zhang","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/1878-0261.12631","article-title":"LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2","volume":"14","author":"Han","year":"2020","journal-title":"Mol. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"118807","DOI":"10.1016\/j.biopha.2025.118807","article-title":"siRNA-based therapeutic candidate targeting PRDM2 for inhibition of lung cancer progression","volume":"193","author":"Kumar","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1038\/s41467-019-13652-x","article-title":"Discovery of a chemical probe for PRDM9","volume":"10","author":"Szewczyk","year":"2019","journal-title":"Nat. Commun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/8\/3392\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:17:48Z","timestamp":1776485868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/8\/3392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":88,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["ijms27083392"],"URL":"https:\/\/doi.org\/10.3390\/ijms27083392","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}